Spencer Paulson, MD
Anatomic Pathology & Clinical Pathology · Tucson, AZNPI 1215290275
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 35.9% of the total.
Across 24 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$173
- Regeneron Healthcare Solutions, Inc.$81
- Celltrion USA Inc.$48
- Ardelyx, Inc.$46
- Intercept Pharmaceuticals, Inc.$30
- AbbVie$30
- plus $72 from 3 others
What the payments were for
- Food & beverage$480100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $173 |
| Regeneron Healthcare Solutions, Inc. | 5 | $81 |
| Celltrion USA Inc. | 2 | $48 |
| Ardelyx, Inc. | 2 | $46 |
| Intercept Pharmaceuticals, Inc. | 2 | $30 |
| AbbVie | 2 | $30 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Johnson & Johnson | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
How this compares
$480 in reported general payments places this provider in the 75th percentile of 153 anatomic pathology & clinical pathology providers in Arizona.
See all anatomic pathology & clinical pathology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Tucson
- Guadalupe ManriquezTucson$1.4M
- Ghassan TraneshTucson$1M
- Michael LynchTucson$833K
- Bharathi VennapusaTucson$419K
- Judith PughTucson$283K
- Peter BanksTucson$264K
- Jennifer ThornTucson$233K
- Anil RamaraoTucson$192K
- Carlos CantuTucson$8K
- Qinglong HuTucson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.